Adrealm aims to rebuild the digital advertising ecosystem and cultivate a self-sustaining open ecosystem for all participants to achieve advertising efficiency. Built on ERC-20 standard of the Ethereum platform, Adrealm connects advertisers, service providers, content publishers, developers etc on its decentralized public ledger ensuring privacy and no third-party management of data. Thanks to its three-tier architecture made of an on-chain layer, off-chain layer, and a service layer, speed and efficiency can be guaranteed and the industry pain-points such as fraud, low-quality ads, and data leakage can be overcome. Adrealm relies on a particular consensus mechanism called Proof of Valid Traffic (PoVT) that makes high-quality ads and traffic the fundamental criteria for the operational success of transactions.

Tokoin is a platform that establishes the digital business identity and reputation of micro, small & medium enterprises (MSME) as acceptable credibility scoring for suppliers and financial institutions. Tokoin aims to: - Build a digital business identity for MSME that represents a valid business reputation - Build a digital ledger for MSME that records real-time transaction data and provides opportunities to distribute the data to the relevant parties in the ecosystem, hence monetizing their data. - Build a digital ledger for MSME that records real-time transaction data and provides opportunities to distribute the data to the relevant parties in the ecosystem, hence monetizing their data. - Grow opportunities by lowering transaction costs, increasing buying power, and providing the previously inaccessibles access for business partnership - Suppress the financial inclusion barriers

Minerva is the world's first reverse merchant processor. We pay transaction fees to approved businesses integrated within the Minerva economy, we don't charge them. Minerva is a platform designed to incentivize the adoption of its OWL token with a new and disruptive economic model.

Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.

Powered by blockchain technology, the little Phil platform is an entirely new way of giving that fixes trust issues with charities using a public ledger, smart contracts and unique digital identities (UDID) to provide givers with the Proof of Need and Proof of Impact required to re-establish trust in giving to charity. Little Phil uses blockchain technology and user experience (UX) designed around a positive psychology framework to allow people to have the oversight, control and emotional connection of a philanthropist, without giving large amounts. People are able to give on their terms through their smartphone and track their giving all the way to the moment it’s received. This will create an engaging experience that makes them genuinely feel the positive impact they have had on their cause. In addition to this, charities will have solutions to their fundraising and exploitation concerns at a much lower cost than they currently incur.

The FinanceX exchange platform enables users to trade using the local currency from a range of countries. This makes trading faster and easier as users can buy/sell cryptocurrencies directly instead of a slower and more difficult method using an intermediate, such as BTC or ETH. It also means that users can trade from many different countries with no added difficulty, setting us apart from other exchanges.